We are live on ! Find out more
SFO

Stokes Family Office Portfolio holdings

AUM $969M
1-Year Est. Return 19.6%
This Fund
S&P 500
This Quarter Est. Return
+3.18%
1 Year Est. Return
+19.6%
3 Year Est. Return
+56.86%
5 Year Est. Return
+67.08%
10 Year Est. Return
AUM
$1.09B
AUM Growth
+$40.3M
Cap. Flow
+$15.6M
Cap. Flow %
1.42%
Top 10 Hldgs %
34.75%
Holding
317
New
52
Increased
150
Reduced
79
Closed
7

Sector Composition

Rank Sector Weight
1 Technology 12.2%
2 Financials 5.61%
3 Communication Services 5.41%
4 Healthcare 3.94%
5 Consumer Staples 3.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTN icon
151
Vail Resorts
MTN
$5.3B
$786K 0.07%
5,919
-3,719
-39% -$547K
BIL icon
152
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.9B
$786K 0.07%
8,600
+2,478
+40% +$227K
TRV icon
153
Travelers Companies
TRV
$80.2B
$784K 0.07%
2,702
+1,212
+81% +$341K
SPYD icon
154
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
$8.78B
$779K 0.07%
+18,000
New +$780K
IBDS icon
155
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
$3.85B
$749K 0.07%
30,869
IWL icon
156
iShares Russell Top 200 ETF
IWL
$2.28B
$739K 0.07%
+4,330
New +$732K
RSP icon
157
Invesco S&P 500 Equal Weight ETF
RSP
$99.5B
$734K 0.07%
3,830
MRK icon
158
Merck
MRK
$318B
$726K 0.07%
6,896
-582
-8% -$54.6K
TFI icon
159
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
$3.14B
$721K 0.07%
15,779
-668
-4% -$30.5K
SCHW
160
Charles Schwab
SCHW
$187B
$719K 0.07%
7,193
+225
+3% +$21.3K
VIOV icon
161
Vanguard S&P Small-Cap 600 Value ETF
VIOV
$1.89B
$716K 0.07%
7,328
+1,478
+25% +$143K
PFE icon
162
Pfizer
PFE
$153B
$715K 0.07%
28,718
+1,589
+6% +$40.1K
IBDY icon
163
iShares iBonds Dec 2033 Term Corporate ETF
IBDY
$1.09B
$712K 0.07%
27,250
IBDZ
164
iShares iBonds Dec 2034 Term Corporate ETF
IBDZ
$868M
$712K 0.07%
27,000
IBDX icon
165
iShares iBonds Dec 2032 Term Corporate ETF
IBDX
$1.72B
$698K 0.06%
27,330
AFL icon
166
Aflac
AFL
$62.6B
$688K 0.06%
6,243
+2,001
+47% +$220K
CMCSA icon
167
Comcast
CMCSA
$90B
$679K 0.06%
22,725
-190
-0.8% -$5.42K
SCHM icon
168
Schwab US Mid-Cap ETF
SCHM
$15.1B
$672K 0.06%
22,344
-44,622
-67% -$1.33M
NVS icon
169
Novartis
NVS
$297B
$662K 0.06%
+4,805
New +$629K
ISRG icon
170
Intuitive Surgical
ISRG
$134B
$656K 0.06%
1,158
+153
+15% +$81.5K
GSIE icon
171
Goldman Sachs ActiveBeta International Equity ETF
GSIE
$6.16B
$646K 0.06%
15,038
-4,936
-25% -$206K
EFG icon
172
iShares MSCI EAFE Growth ETF
EFG
$17.3B
$637K 0.06%
5,591
+1,047
+23% +$120K
IJH icon
173
iShares Core S&P Mid-Cap ETF
IJH
$127B
$635K 0.06%
9,623
+1,645
+21% +$108K
IXUS icon
174
iShares Core MSCI Total International Stock ETF
IXUS
$60.1B
$627K 0.06%
7,403
-114
-2% -$9.56K
TMO icon
175
Thermo Fisher Scientific
TMO
$220B
$616K 0.06%
1,063
+315
+42% +$178K

Similar funds

Stokes Family Office's Q4 2025 Portfolio in Review

As of Q4 2025, Stokes Family Office held 317 positions worth $1.09B, up 3.8% from $1.05B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Stokes Family Office's Q4 2025 filing shows 52 new, 150 increased, 79 reduced and 7 closed positions. Its largest new stake was iShares A.I. Innovation and Tech Active ETF: 332,388 shares worth $11.1M. The largest sale was Vanguard Dividend Appreciation ETF, an estimated $21M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Financials and Communication Services.

  • Stokes Family Office's largest Q4 2025 buy was iShares A.I. Innovation and Tech Active ETF: 332,388 shares worth $11.1M.
  • Stokes Family Office added most to iShares S&P 500 Value ETF in Q4 2025, an estimated $8.58M increase.
  • Stokes Family Office's biggest Q4 2025 reduction was Vanguard Dividend Appreciation ETF, cutting an estimated $21M.
  • Stokes Family Office fully exited iShares iBonds Dec 2025 Term Corporate ETF in Q4 2025, selling an estimated $742K.
  • Stokes Family Office's ten largest holdings make up 35% of its $1.09B portfolio in Q4 2025.
  • Stokes Family Office opened 52 new positions and closed 7 in Q4 2025.
  • Stokes Family Office's portfolio value rose 3.8% quarter-over-quarter to $1.09B.

Based on Stokes Family Office's 13F filing for Q4 2025, filed 18 Feb 2026.